W&L Now Taking Ovarian Cancer Diagnosed After Talc UseMay 25th, 2016
Weitz & Luxenberg P.C. is now taking cases involving women who have used talc powders for personal feminine hygiene regularly and consistently for several years and were subsequently diagnosed with ovarian cancer.
Weitz & Luxenberg P.C is looking for cases in which women were using talc powders for personal feminine hygiene and were subsequently diagnosed with any of these ovarian cancer types:
- Serous epithelial ovarian carcinoma
- Endometrioid epithelial ovarian cancer
- Mucinous epithelial ovarian cancer
- Clear cell ovarian cancer
- Undifferentiated ovarian cancer
”Ovarian cancer from using talc for personal feminine hygiene is a condition that has affected thousands of women and grievously impacted their lives — in some cases resulting in death,” said W&L’s Ellen Relkin, of counsel attorney.
Talc Ovarian Cancer Risk Long Known
For many years, studies have suggested a link between ovarian cancer and women who regularly used talc powder for personal female hygiene. A 2013 study by Terry et al., published in Cancer Prevention Research, found a 20 to 30 percent increased risk of different types of ovarian cancer with personal feminine hygiene powder use. These authors also observed a significant 1.46 times increased risk for borderline serous ovarian tumors.
Another study published in 2015 by Cramer et al., published in the journal Epidemiology, found similarly increased magnitude of risk, with a trend in their data indicating increased risk with increased talc use.
The largest manufacturer of talc powder products is Johnson & Johnson of New Brunswick, New Jersey. It manufacturers Shower to Shower and Johnson & Johnson Baby Powder.
Another manufacturer of talc-containing powders is Chattem, Inc., of Chattanooga, Tennessee, which manufactures Gold Bond Body Powder, Gold Bond Extra Strength Body Powder, and Gold Bond No Mess Powder Spray, all of which contain talc. Chattem is a subsidiary of Paris-based Sanofi.
W&L Can Help Victims of Failure to Warn of Talc and Ovarian Cancer Link
In February and May 2016, St. Louis, Missouri, juries found Johnson & Johnson liable for a combined total of $127 million in two separate trials involving women who used the company’s talc powder products that subsequently developed ovarian cancer.
The plaintiffs in those two cases contended that Johnson & Johnson had long known about the ovarian cancer risk accompanying use of talc for personal hygiene use, but gave consumers no warnings. The plaintiffs produced evidence of internal Johnson & Johnson documents substantiating these claims.
The juries decided to increase the plaintiffs’ compensation awards by adding $50 million and $62 million, respectively, in punitive damages.
Women who used talc power for personal feminine hygiene and were diagnosed with ovarian cancer should contact W&L to discuss their rights to compensation for medical treatment, lost income and other damages.
To arrange a free consultation, contact W&L toll-free at 844-400-HELP or reach us online by using our form or live chat.